Literature DB >> 1854657

Protective effects of felodipine and verapamil against imipramine-induced lethal cardiac conduction disturbances in the anaesthetized rat.

D F Schoors1, H Reynaert, L Huyghens, L Vanhaelst, A G Dupont.   

Abstract

The effect of verapamil and felodipine on imipramine-induced cardiac toxicity was assessed in anaesthetized rats. Rats received either infusion of saline (n = 13), or non-hypotensive doses of felodipine (n = 36) or verapamil (n = 36) over 40 minutes. In saline-pretreated rats IV bolus injection of imipramine (10 mg/kg) resulted in severe hypotension, bradycardia, electromechanical dissociation, and death within 3 minutes. Rats pretreated with nonhypotensive doses of felodipine (1, 3, 6, and 10 micrograms/kg/min) or verapamil (10, 30, 100, and 300 micrograms/kg/min) survived throughout the experiment, despite an initial fall in blood pressure within the first 5 minutes after imipramine administration. Blood pressure returned to baseline levels within 15 minutes. Intermittent ECG monitoring showed significant prolongation of QRS duration after imipramine in both saline (by 138%) and verapamil-pretreated rats (by 63%), whereas in the rats pretreated with felodipine no prolongation was observed (+3%). We conclude that, in our experimental model, felodipine, more than verapamil, protects against the cardiac effects of imipramine intoxication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854657     DOI: 10.1007/bf03029774

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  22 in total

Review 1.  Increasing complexity revealed in regulation of Ca2+ antagonist receptor.

Authors:  T Godfraind; S Govoni
Journal:  Trends Pharmacol Sci       Date:  1989-08       Impact factor: 14.819

Review 2.  Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage.

Authors:  D W Choi
Journal:  Trends Neurosci       Date:  1988-10       Impact factor: 13.837

Review 3.  Role of Ca2+ in toxic cell killing.

Authors:  S Orrenius; D J McConkey; G Bellomo; P Nicotera
Journal:  Trends Pharmacol Sci       Date:  1989-07       Impact factor: 14.819

4.  Effects of felodipine on red blood cell deformability.

Authors:  R J Hopkins; T W Hill
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 5.  Calcium antagonists and sympathetic neuroeffector function.

Authors:  D C Eikenburg; M F Lokhandwala
Journal:  J Auton Pharmacol       Date:  1986-09

Review 6.  Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.

Authors:  J B Marshall; A D Forker
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

7.  Interaction of the antihypertensive drug felodipine with calmodulin.

Authors:  S L Bostróm; B Ljung; S Mårdh; S Forsen; E Thulin
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

Review 8.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Ca2+ modulators as antidotes to imipramine and neurotransmitter toxicity.

Authors:  R Trouve; G Nahas
Journal:  Proc Soc Exp Biol Med       Date:  1987-09

10.  Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity.

Authors:  J T Niemann; H A Bessen; R J Rothstein; M M Laks
Journal:  Am J Cardiol       Date:  1986-05-01       Impact factor: 2.778

View more
  1 in total

1.  Influences of the calcium antagonists nicardipine and nifedipine, and the calcium agonist BAY-K-8644, on the pharmacokinetics of propranolol in rats.

Authors:  I Vercruysse; D F Schoors; D L Massart; A G Dupont
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.